Revenue: The sum of all revenue fields included for a company's operating activities.
REGENXBIO Inc. (RGNX) had Revenue of $83.33M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$83.33M |
$-227.10M |
|
$33.57M |
|
$49.76M |
|
$316.67M |
|
$-233.35M |
|
$6.24M |
|
$-227.10M |
|
$-227.10M |
|
$-227.10M |
|
$-227.10M |
|
$-227.10M |
|
$-227.10M |
|
$-233.35M |
|
$-221.28M |
|
49.51M |
|
49.51M |
|
$-4.59 |
|
$-4.59 |
|
| Balance Sheet Financials | |
$278.00M |
|
$117.59M |
|
$187.99M |
|
$465.99M |
|
$103.19M |
|
-- |
|
$103.14M |
|
$206.34M |
|
$259.65M |
|
$259.65M |
|
$259.65M |
|
49.55M |
|
| Cash Flow Statement Financials | |
$-173.12M |
|
$103.45M |
|
$92.68M |
|
$36.55M |
|
$59.56M |
|
$23.00M |
|
$38.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
59.72% |
|
-280.03% |
|
-280.03% |
|
-265.55% |
|
-272.54% |
|
-272.54% |
|
$-175.56M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
-- |
|
4.07 |
|
89.68 |
|
-87.46% |
|
-87.46% |
|
-48.74% |
|
-87.46% |
|
$5.24 |
|
$-3.55 |
|
$-3.50 |
|